Chris Guise

(Former)

View graph of relations

Recent publications

Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: Effects of combining beneficial single mutations
Simon Vass, Chris Guise, Jane Grove, Eva Hyde & Peter Searle, 15 Jan 2010, In: Biochemical Pharmacology. 79, 2, p. 102-111 10 p.

Research output: Contribution to journal › Article › peer-review

Steady-State and Stopped-Flow Kinetic Studies of Three Escherichia coli NfsB Mutants with Enhanced Activity for the Prodrug CB1954
Chris Guise, Scott White, Peter Searle & Eva Hyde, 1 Aug 2009, In: Biochemistry. 48, 32, p. 7665-7672 8 p.

Research output: Contribution to journal › Article › peer-review

Nitroreductase: A prodrug-activating enzyme for cancer gene therapy
Peter Searle, Andrew Lovering, Jane Grove, Chris Guise, Nicholas James, Vivien Mautner, Lawrence Young, David Kerr, Scott White & Eva Hyde, 1 Nov 2004, In: Clinical and Experimental Pharmacology and Physiology. 31, 11, p. 811-816 6 p.

Research output: Contribution to journal › Article › peer-review

View all (4)